Pages that link to "Q30823193"
Jump to navigation
Jump to search
The following pages link to Cost-of-illness studies of depression: a systematic review (Q30823193):
Displaying 50 items.
- Clinical implications of the Women's Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomes (Q26861338) (← links)
- Cost-effectiveness of collaborative care for the treatment of depressive disorders in primary care: a systematic review (Q27024741) (← links)
- The attributable annual health costs of U.S. occupational lead poisoning (Q28386648) (← links)
- The unknown burden and cost of celiac disease in the U.S. (Q30234960) (← links)
- Preventing Depression in Adults With Subthreshold Depression: Health-Economic Evaluation Alongside a Pragmatic Randomized Controlled Trial of a Web-Based Intervention (Q30490626) (← links)
- Preventing the onset of major depression based on the level and profile of risk of primary care attendees: protocol of a cluster randomised trial (the predictD-CCRT study). (Q30541071) (← links)
- Systematic review and assessment of validated case definitions for depression in administrative data (Q30861280) (← links)
- Health care costs of borderline personality disorder and matched controls with major depressive disorder: a comparative study based on anonymized claims data. (Q31149890) (← links)
- Clinical and cost-effectiveness of computerised cognitive behavioural therapy for depression in primary care: design of a randomised trial (Q33347829) (← links)
- Cost-effectiveness analysis of cognitive behaviour therapy for treatment of minor or mild-major depression in elderly patients with type 2 diabetes: study protocol for the economic evaluation alongside the MIND-DIA randomized controlled trial (MIND- (Q33477135) (← links)
- Using electronic data sources to understand the determinants of psychiatric visit non-adherence (Q33547373) (← links)
- Cognitive-reminiscence therapy and usual care for depression in young adults: study protocol for a randomized controlled trial (Q33591178) (← links)
- Health costs in patients treated for depression, in patients with depressive symptoms treated for another chronic disorder, and in non-depressed patients: a two-year prospective cohort study in anthroposophic outpatient settings (Q33629358) (← links)
- Within-trial economic evaluation of diabetes-specific cognitive behaviour therapy in patients with type 2 diabetes and subthreshold depression (Q33722817) (← links)
- Long-term effects of the treatment of depressive female inpatients in a naturalistic study: is early improvement a valid predictor of outcome? (Q33908224) (← links)
- Prevalence of DSM-IV major depression among U.S. military personnel: meta-analysis and simulation. (Q33909008) (← links)
- Atypical Epidemiologic Finding in Association between Depression and Alcohol Use or Smoking in Korean Male: Korean Longitudinal Study of Aging. (Q34012231) (← links)
- Inclusion of women and gender-specific analyses in randomized clinical trials of treatments for depression (Q34115025) (← links)
- Does GP training in depression care affect patient outcome? - A systematic review and meta-analysis (Q34123192) (← links)
- Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting (Q34169177) (← links)
- Reward dysfunction in major depression: multimodal neuroimaging evidence for refining the melancholic phenotype (Q34195839) (← links)
- Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review (Q34224379) (← links)
- Resource utilisation and costs of depressive patients in Germany: results from the primary care monitoring for depressive patients trial (Q34245326) (← links)
- Internet-based treatment of major depression for patients on a waiting list for inpatient psychotherapy: protocol for a multi-centre randomised controlled trial (Q34465439) (← links)
- The effects of reminiscence therapy on depressive symptoms of Chinese elderly: study protocol of a randomized controlled trial (Q34466909) (← links)
- Adult depression screening in Saudi primary care: prevalence, instrument and cost (Q34485868) (← links)
- Training working memory to reduce rumination (Q35111168) (← links)
- Cost of depression among adults in Japan (Q35251978) (← links)
- Neural response to reward and depressive symptoms in late childhood to early adolescence (Q35633116) (← links)
- Fish consumption and resilience to depression in Japanese company workers: a cross-sectional study. (Q35659254) (← links)
- Examining antidepressant drug response by smoking status: why is it important and how often is it done? (Q35667964) (← links)
- Association between eating alone and depressive symptom in elders: a cross-sectional study (Q35895950) (← links)
- Association between regular physical exercise and depressive symptoms mediated through social support and resilience in Japanese company workers: a cross-sectional study (Q36074101) (← links)
- Life satisfaction and frequency of doctor visits (Q36168530) (← links)
- Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial protocol. (Q36181601) (← links)
- Estimating the prevalence of depression associated with healthcare use in France using administrative databases. (Q36238945) (← links)
- Depressive symptoms and psychosocial stress at work among older employees in three continents (Q36416540) (← links)
- Effect of newly synthesized 1,2,4-triazino[5,6-b]indole-3-thione derivatives on olfactory bulbectomy induced depression in rats. (Q36752924) (← links)
- Evaluating the translation process of an Internet-based self-help intervention for prevention of depression: a cost-effectiveness analysis (Q36794214) (← links)
- Dorsolateral prefrontal transcranial magnetic stimulation in patients with major depression locally affects alpha power of REM sleep (Q37064789) (← links)
- Incarcerating juveniles in adult prisons as a factor in depression (Q37068220) (← links)
- Desvenlafaxine: another "me too" drug? (Q37242256) (← links)
- Fifteen-year follow-up of a randomized trial of a preventive intervention for divorced families: effects on mental health and substance use outcomes in young adulthood (Q37247858) (← links)
- Nonresponse, partial response, and failure to achieve remission: humanistic and cost burden in major depressive disorder (Q37285959) (← links)
- Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women's Ischemia Syndrome Evaluation) Study (Q37316049) (← links)
- Effectiveness of a novel integrative online treatment for depression (Deprexis): randomized controlled trial (Q37389282) (← links)
- Determinants of direct cost differences among US employees with major depressive disorders using antidepressants (Q37565504) (← links)
- Methodological Considerations in Social Cost Studies of Addictive Substances: A Systematic Literature Review (Q37590519) (← links)
- A Breathing-Based Meditation Intervention for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants: A Randomized Pilot Study (Q37610768) (← links)
- Online Positive Interventions to Promote Well-being and Resilience in the Adolescent Population: A Narrative Review (Q37611800) (← links)